Chitogenx (CHGX.CN) Stock Price

Chitogenx Price

CLOSED
0.00
​
Market closed

Chitogenx stock price

Access this data via the Eulerpool API

Chitogenx business model & stock analysis

ChitogenX, Inc. is a clinical stage biotech company, which engages in the development of therapeutic soft tissue repair technologies for orthopaedic and sports medicine surgeries. The company is headquartered in Kirkland, Quebec. The company went IPO on 2017-10-10. The firm is engaged in the development of therapeutic soft tissue repair technologies to improve the success rate of orthopedic and sports medicine surgeries. The Company’s proprietary biopolymer has been specifically designed to increase the healing rates of occupational and sports related injuries to tendons, ligaments, meniscus and cartilage. The biopolymer, autologous platelet-rich plasma (PRP) combination implant, can be directly placed into the site of injuries by surgeons during routine operative procedures without significantly extending the duration of surgeries and without further interventions. The firm assess its potential for therapeutic uses outside of the soft tissue repair market. The Company, through Ecole Polytechnique and two industrial partners, delineates the PRP components, the distinct impact of each component and their collective action towards tissue repair.

Frequently asked questions about Chitogenx

7 analysts currently rate the Chitogenx stock: 6 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Chitogenx share trades at 0.00 EUR (0.00 CAD).

The revenue cannot currently be calculated for Chitogenx.

The expected profit of Chitogenx is -9.33 M CAD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Chitogenx is currently -0.04. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Chitogenx stock.

The P/S cannot be calculated for Chitogenx currently.

The Eulerpool Quality Score for Chitogenx is 2/10.

The ISIN of Chitogenx is CA1699161032. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Chitogenx is CHGX.CN. The ticker symbol is used to trade Chitogenx shares on the stock exchange.

Fair ValueTerminal
0.00 CAD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CAD
Initial public offering
Oct 10, 2017
ISIN
CA1699161032
Cusip
169916103
Market capitalization
52-Week Range
PEG
—
P/E ratio
P/Ee 2025
-0.07
P/Ee 2026
-0.04
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
—
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
67.48 %
Last updated Oct 10, 2026, 3:43 PM

Chitogenx Peer Group

Chitogenx FIGI

CHGX:CN · BBG009SXPPN9CHGX:CF · BBG00BJZP2F9CHGX:TG · BBG00BJZP2T4CHGX:TW · BBG00BJZP2W0CHGX:DG · BBG00BJZP330CHGX:QF · BBG00BJZP349CHGX:QH · BBG00BJZP358CHGX:TO · BBG00G8YLG39CHNXF:US · BBG00JGGDDD8CHNXF:PQ · BBG00JGGDDS2CHNXF:UV · BBG00JGGDDT1CHGX:DL · BBG00K7X5BF9